Clorox Co (NYSE:CLX) was the recipient of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 11,000,000 shares, a decrease of 9.2% from the June 15th total of 12,110,000 shares. Based on an average daily trading volume, of 2,060,000 shares, the days-to-cover ratio is presently 5.3 days. Approximately 8.8% of the shares of the company are short sold.
Shares of NYSE:CLX traded up $3.51 during midday trading on Thursday, hitting $229.08. The company had a trading volume of 34,482 shares, compared to its average volume of 1,636,558. Clorox has a twelve month low of $144.12 and a twelve month high of $226.73. The company has a debt-to-equity ratio of 3.69, a current ratio of 0.98 and a quick ratio of 0.72. The stock has a market cap of $28.41 billion, a price-to-earnings ratio of 33.68, a price-to-earnings-growth ratio of 5.35 and a beta of 0.27. The business’s 50-day simple moving average is $209.05 and its 200-day simple moving average is $181.46.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Friday, May 1st. The company reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. Clorox had a return on equity of 147.52% and a net margin of 13.67%. The firm had revenue of $1.78 billion during the quarter, compared to analysts’ expectations of $1.69 billion. During the same quarter last year, the firm earned $1.44 earnings per share. The business’s revenue for the quarter was up 15.0% on a year-over-year basis. As a group, sell-side analysts forecast that Clorox will post 6.91 EPS for the current year.
A number of equities analysts have issued reports on the company. DA Davidson assumed coverage on Clorox in a research report on Monday, June 29th. They set a “buy” rating on the stock. Morgan Stanley increased their price target on Clorox from $173.00 to $177.00 and gave the stock an “underweight” rating in a research report on Monday, May 4th. Cfra raised their target price on Clorox from $170.00 to $190.00 and gave the company a “hold” rating in a research report on Friday, May 1st. Barclays restated a “sell” rating and issued a $164.00 target price on shares of Clorox in a research report on Tuesday, May 5th. Finally, JPMorgan Chase & Co. upgraded Clorox from an “underweight” rating to an “overweight” rating and raised their target price for the company from $153.00 to $185.00 in a research report on Monday, March 16th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $173.62.
In other Clorox news, SVP Denise Garner sold 25,832 shares of the stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $197.62, for a total transaction of $5,104,919.84. Following the transaction, the senior vice president now owns 17,468 shares in the company, valued at $3,452,026.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Diego J. Barral sold 11,031 shares of the stock in a transaction that occurred on Tuesday, May 5th. The stock was sold at an average price of $203.60, for a total value of $2,245,911.60. Following the transaction, the senior vice president now owns 20,037 shares in the company, valued at approximately $4,079,533.20. The disclosure for this sale can be found here. Insiders sold 73,011 shares of company stock worth $14,788,606 in the last 90 days. Company insiders own 1.14% of the company’s stock.
A number of hedge funds have recently bought and sold shares of CLX. Coastal Capital Group Inc. acquired a new stake in Clorox during the first quarter worth $25,000. Simon Quick Advisors LLC increased its stake in Clorox by 1,522.2% during the first quarter. Simon Quick Advisors LLC now owns 146 shares of the company’s stock worth $25,000 after acquiring an additional 137 shares during the last quarter. Asset Dedication LLC acquired a new stake in Clorox during the first quarter worth $25,000. Evolution Wealth Advisors LLC increased its stake in Clorox by 581.8% during the first quarter. Evolution Wealth Advisors LLC now owns 150 shares of the company’s stock worth $26,000 after acquiring an additional 128 shares during the last quarter. Finally, Fred Alger Management LLC acquired a new stake in Clorox during the first quarter worth $28,000. 78.75% of the stock is owned by institutional investors.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Capital Gains Distribution
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.